Page last updated: 2024-09-04

ivabradine and Diabetes Mellitus, Type 2

ivabradine has been researched along with Diabetes Mellitus, Type 2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laínez, S; McNaughton, PA; Mehta, I; Tsantoulas, C; Vilar, B; Wong, S1
Fomin, IV; Valikulova, FIu1
Dolgikh, VT; Kondrat'ev, AI; Stotskiĭ, AO1
Crea, F; Di Franco, A; Ghirlanda, G; Lanza, GA; Milo, M; Nerla, R; Pitocco, D; Russo, G; Sarullo, FM; Stazi, A; Tarzia, P; Villano, A; Zaccardi, F1

Trials

2 trial(s) available for ivabradine and Diabetes Mellitus, Type 2

ArticleYear
[Antianginal effect of long-term use of ivabradine in patients with ischemic heart disease and diabetes in ambulatory conditions].
    Kardiologiia, 2009, Volume: 49, Issue:3

    Topics: Adrenergic Antagonists; Aged; Ambulatory Care; Angina Pectoris; Benzazepines; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Treatment Outcome

2009
Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients.
    Heart (British Cardiac Society), 2012, Volume: 98, Issue:24

    Topics: Atenolol; Benzazepines; Brachial Artery; Cardiovascular Diseases; Cyclic Nucleotide-Gated Cation Channels; Diabetes Mellitus, Type 2; Double-Blind Method; Electrocardiography; Endothelium, Vascular; Female; Follow-Up Studies; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Sympathetic Nervous System; Sympatholytics; Vasodilation

2012

Other Studies

3 other study(ies) available for ivabradine and Diabetes Mellitus, Type 2

ArticleYear
Hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy.
    Science translational medicine, 2017, Sep-27, Volume: 9, Issue:409

    Topics: Analgesics; Animals; Benzazepines; Cyclic AMP; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Models, Animal; Gene Deletion; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Nociception; Pain; Potassium Channels; Proto-Oncogene Proteins c-fos; Sensory Receptor Cells; Skin; Spinal Cord Dorsal Horn; Streptozocin

2017
DTB Select: 7 | July 2014.
    Drug and therapeutics bulletin, 2014, Volume: 52, Issue:7

    Topics: Alcohol-Related Disorders; Benzazepines; Diabetes Mellitus, Type 2; Drug Resistance, Multiple, Bacterial; Exercise Therapy; Humans; Hydroxyzine; Incretins; Ivabradine; Mass Screening; Medication Errors; Osteoarthritis, Hip; Tumor Necrosis Factor-alpha

2014
[Efficacy of ivabradine in combination therapy for complicated acute coronary syndrome in patients with type 2 diabetes mellitus].
    Terapevticheskii arkhiv, 2010, Volume: 82, Issue:1

    Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Adult; Benzazepines; Diabetes Mellitus, Type 2; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Hypoglycemic Agents; Ivabradine; Male; Metoprolol; Middle Aged; Treatment Outcome; Ventricular Function, Left

2010